Assessment of adult phenylketonuria

Annals of Clinical Biochemistry

Volumn 38, Issue 5, 2001, Pages 450-458

  Cleary, M ^a   Walter, J H ^a  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE; TYROSINE;

AUTOSOMAL RECESSIVE INHERITANCE; BRAIN MAPPING; DIET RESTRICTION; DIET THERAPY; HUMAN; HYPERPHENYLALANINEMIA; INBORN ERROR OF METABOLISM; MEDICAL RESEARCH; NEUROLOGIC DISEASE; NEWBORN SCREENING; NUTRITIONAL DEFICIENCY; PHENYLKETONURIA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ADULT; ANIMALS; AVITAMINOSIS; CHILD; DIETARY SUPPLEMENTS; GENE THERAPY; HEALTH EDUCATION; HUMANS; PHENYLALANINE; PHENYLKETONURIAS; SURVIVORS;

EID: 0034847228     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563011901217     Document Type: Review

References (65)

1. Routine neonatal screening for phenylketonuria in the United Kingdom 1964-78
2. Phenylketonuria
3. Influence of phenylalanine intake on phenylketonuria
4. The influence of phenylalanine intake on the chemistry and behavior of a phenylketonuric child
5. Treatment of phenylketonuria with a diet low in phenylalanine
6. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants
7. After a positive Guthrie - What next? Dietary management for the child with phenylketonuria
8. The hyperphenylalaninemias
9. Disturbed myelination in patients with treated hyperphenylalaninaemia: Evaluation with magnetic resonance imaging
10. Neurological deterioration in adult phenylketonuria
11. Neurological deterioration in young adults with phenylketonuria
12. Phenylketonuria due to phenylalanine hydroxylase deficiency: An unfolding story
13. Recommendations on the dietary management of phenylketonuria. Report of Medical Research Council Working Party on Phenylketonuria
14. An investigation into diet treatment for adults with previously untreated phenylketonuria and severe intellectual disability
15. The hyperphenylalaninaemias
16. Modern techniques of differentiating the various phenotypes of phenylketonuria
17. Molecular structure and polymorphic map of the human phenylalanine hydroxylase gene
18. Sequence variation at the phenylalanine hydroxylase gene in the British Isles
19. Neuropathology of phenylketonuria
20. Neuropathologic observations in phenylketonuria
21. On the mechanism of permanent brain dysfunction in hyperphenylalaninemia
22. Evidence for central nervous system glial cell plasticity in phenylketonuria
23. Late effects of phenylketonuria
24. Intelligence and behaviour in children with early treated phenylketonuria. A report from the MRC/DHSS Phenylketonuria Register
25. Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria
26. Behavior disturbance in 8-year-old children with early treated phenylketonuria. Report from the MRC/DHSS Phenylketonuria Register
27. Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man
28. EEGs in phenylketonuria. I: Follow-up to adulthood; II: Short-term diet-related changes in EEGs and cognitive function
29. Early-treated phenylketonuria: Neuropsychologic consequences
30. Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction
31. Neuropsychology of early-treated phenylketonuria: Specific executive function deficits
32. Phenylketonuria and complex spatial visualization: An analysis of information processing
33. An animal model of early-treated PKU
34. Unexpected white matter changes in an early treated PKU case and improvement after dietary treatment
35. Brain MRI changes in phenylketonuria. Associations with dietary status
36. Magnetic resonance imaging of the brain in phenylketonuria
37. White matter abnormalities in patients with treated hyperphenylalaninaemia: Magnetic resonance relaxometry and proton spectroscopy findings
38. Neuropsychological deficits in early treated phenylketonuric children
39. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU
40. Factors affecting cognitive, motor, behavioral and executive functioning in children with phenylketonuria
41. Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria
42. An occipito-temporal syndrome in adolescents with optimally controlled hyperphenylalaninaemia
43. Neuropsychological studies on adolescents with phenylketonuria returned to phenylalanine-restricted diets
44. Phenylketonuria: MR imaging of the brain with clinical correlation
45. Magnetic resonance imaging in phenylketonuria: Reversal of cerebral white matter change
46. Phenylketonuria: Findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment
47. Brain phenylalanine concentration in the management of adults with phenylketonuria
48. In-vivo NMR spectroscopy in patients with phenylketonuria: Changes of cerebral phenylalanine levels under dietary treatment
49. Kinetics of phenylalanine transport at the human blood-brain barrier investigated in vivo
50. Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria
51. In vivo NMR spectroscopy in patients with phenylketonuria: Clinical significance of interindividual differences in brain phenylalanine concentrations
52. Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997
53. Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet
54. Vitamin B12 deficiency in an adult phenylketonuric patient
55. Vitamin B12 deficiency in adolescents and young adults with phenylketonuria
56. Spastic paraparesis after anaesthesia
57. Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus
58. The North American Collaborative Study of Maternal Phenylketonuria. Status report 1993
59. Outcome implications of the International Maternal Phenylketonuria Collaborative Study (MPKUCS): 1994
60. Effects of dietary mixtures of amino acids on fetal growth and maternal and fetal amino acid pools in experimental maternal phenylketonuria
61. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria
62. A different approach to treatment of phenylketonuria: Phenylalanine degradation with recombinant phenylalanine ammonia lyase
63. Gene therapy for phenylketonuria: Phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer
64. Gene therapy for phenylketonuria